Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Celecoxib × Clear all

NCT01881048 2026-01-29

Window of Opportunity Study Targeting the Inflammatory Milieu

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT03599453 2023-07-18

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Phase EARLY_PHASE1 Completed

Triple Negative Breast Neoplasms